Pharmaceutical companies held most of their traditional January list-price increases to under 10% this year, although the median boost was little-changed from 2016. Among the critics they face now is President Trump.
from WSJ.com: US Business http://ift.tt/2lVo0a8
via IFTTT
No comments:
Post a Comment